Gnanapavan S, Ho P, Heywood W, Jackson S, Grant D, Rantell K, et al. Progression in multiple sclerosis is associated with low endogenous NCAM. J Neurochem. 2013;125(5):766–73. https://doi.org/10.1111/jnc.12236.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baskaran AB, Grebenciucova E, Shoemaker T, Graham EL. Current updates on the diagnosis and management of multiple sclerosis for the general neurologist. J Clin Neurol. 2023;19(3):217–29. https://doi.org/10.3988/jcn.2022.0208.PMID:37151139;PMCID:PMC10169923.

Article  PubMed  PubMed Central  Google Scholar 

Rovira A, Auger C, Alonso J. Magnetic resonance monitoring of lesion evolution in multiple sclerosis. Ther Adv Neurol Disord. 2013;6(5):298–310. https://doi.org/10.1177/1756285613484079.

Article  PubMed  PubMed Central  Google Scholar 

Gokce SF, Bolayır A, Cigdem B, Yildiz B. The role of systemic ımmune ınflammatory ındex in showing active lesion ın patients with multiple sclerosis : SII and other inflamatuar biomarker in radiological active multiple sclerosis patients. BMC Neurol. 2023;23(1):64. https://doi.org/10.1186/s12883-023-03101-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Miller JM, Beales JT, Montierth MD, Briggs FB, Frodsham SF, Davis MF. The Impact of Multiple Sclerosis Disease Status and Subtype on Hematological Profile. Int J Environ Res Public Health. 2021;18(6):3318. https://doi.org/10.3390/ijerph18063318.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lauer K. Environmental risk factors in multiple sclerosis. Expert Rev Neurother. 2010;10(3):421–40. https://doi.org/10.1586/ern.10.7.

Article  PubMed  Google Scholar 

Perry VH, Cunningham C, Holmes C. Systemic infections and inflammation affect chronic neurodegeneration. Nat Rev Immunol. 2007;7(2):161–7. https://doi.org/10.1038/nri2015.

Article  CAS  PubMed  Google Scholar 

Barkhane Z, Elmadi J, Satish Kumar L, Pugalenthi LS, Ahmad M, Reddy S. Multiple sclerosis and autoimmunity: a veiled relationship. Cureus. 2022;14(4): e24294. https://doi.org/10.7759/cureus.24294.

Article  PubMed  PubMed Central  Google Scholar 

Dendrou CA, Fugger L, Friese MA. Immunopathology of multiple sclerosis. Nat Rev Immunol. 2015;15(9):545–58. https://doi.org/10.1038/nri3871.

Article  CAS  PubMed  Google Scholar 

Trapp BD, Nave KA. Multiple sclerosis: an immune or neurodegenerative disorder? Annu Rev Neurosci. 2008;31:247–69. https://doi.org/10.1146/annurev.neuro.30.051606.094313.

Article  CAS  PubMed  Google Scholar 

Attfield KE, Jensen LT, Kaufmann M, Friese MA, Fugger L. The immunology of multiple sclerosis. Nat Rev Immunol. 2022;22(12):734–50. https://doi.org/10.1038/s41577-022-00718-z.

Article  CAS  PubMed  Google Scholar 

Ocana A, Nieto-Jiménez C, Pandiella A, Templeton AJ. Neutrophils in cancer: prognostic role and therapeutic strategies. Mol Cancer. 2017;16(1):137. https://doi.org/10.1186/s12943-017-0707-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kuyumcu ME, Yesil Y, Oztürk ZA, Kizilarslanoğlu C, Etgül S, Halil M, et al. The evaluation of neutrophil-lymphocyte ratio in Alzheimer’s disease. Dement Geriatr Cogn Disord. 2012;34(2):69–74. https://doi.org/10.1159/000341583.

Article  PubMed  Google Scholar 

Kalelioglu T, Yuruyen M, Gultekin G, Yavuzer H, Özturk Y, Kurt M, et al. Neutrophil and platelet to lymphocyte ratios in people with subjective, mild cognitive impairment and early Alzheimer’s disease. Psychogeriatrics. 2017;17(6):506–8. https://doi.org/10.1111/psyg.12260.

Article  PubMed  Google Scholar 

Fahmi RM, Ramadan BM, Salah H, Elsaid AF, Shehta N. Neutrophil-lymphocyte ratio as a marker for disability and activity in multiple sclerosis. Mult Scler Relat Disord. 2021;51: 102921. https://doi.org/10.1016/j.msard.2021.102921.

Article  CAS  PubMed  Google Scholar 

Wang X, Qiu L, Li Z, Wang XY, Yi H. Understanding the multifaceted role of neutrophils in cancer and autoimmune diseases. Front Immunol. 2018;9:2456. https://doi.org/10.3389/fimmu.2018.02456.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kasprzycka W, Nieśpiałowska M, Jakubowska-Solarska B. Blood count parameters in the course of multiple sclerosis. J Transfusion Med. 2019;12(3):117–23. https://doi.org/10.5603/JTM.2019.0007.

Article  Google Scholar 

Groen K, Maltby VE, Sanders KA, Scott RJ, Tajouri L, Lechner-Scott J. Erythrocytes in multiple sclerosis - forgotten contributors to the pathophysiology? Mult Scler J Exp Transl Clin. 2016;19(2):2055217316649981. https://doi.org/10.1177/2055217316649981.

Article  Google Scholar 

Nowak J, Wender M. Reduced expression of erythrocyte complement receptor (C3bR) in MS. Acta Neurol Scand. 1994;89(4):266–9. https://doi.org/10.1111/j.1600-0404.1994.tb01678.x.

Article  CAS  PubMed  Google Scholar 

Melhorn MI, Brodsky AS, Estanislau J, Khoory JA, Illigens B, Hamachi I, et al. CR1-mediated ATP release by human red blood cells promotes CR1 clustering and modulates the immune transfer process. J Biol Chem. 2013;288(43):31139–53. https://doi.org/10.1074/jbc.M113.486035.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin L, Ji M, Wu Y, Hang H, Lu J. Neutrophil to lymphocyte ratio may be a useful marker in distinguishing MOGAD and MS and platelet to lymphocyte ratio associated with MOGAD activity. Mult Scler Relat Disord. 2023;71: 104570. https://doi.org/10.1016/j.msard.2023.104570.

Article  CAS  PubMed  Google Scholar 

Li B, Zhou P, Liu Y, Wei H, Yang X, Chen T, et al. Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis. Clin Chim Acta. 2018;483:48–56. https://doi.org/10.1016/j.cca.2018.04.023.

Article  CAS  PubMed  Google Scholar 

Ravindra R, Ramamurthy P, Aslam SSM, Kulkarni A, K S, Ramamurthy PS. Platelet Indices and Platelet to Lymphocyte Ratio (PLR) as Markers for Predicting COVID-19 Infection Severity. Cureus. 2022;14(8):e28206. https://doi.org/10.7759/cureus.28206.

Article  PubMed  PubMed Central  Google Scholar 

Orian JM, D’Souza CS, Kocovski P, Krippner G, Hale MW, Wang X, et al. Platelets in Multiple Sclerosis: Early and Central Mediators of Inflammation and Neurodegeneration and Attractive Targets for Molecular Imaging and Site-Directed Therapy. Front Immunol. 2021;12: 620963. https://doi.org/10.3389/fimmu.2021.620963.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hemond CC, Glanz BI, Bakshi R, Chitnis T, Healy BC. The neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratios are independently associated with neurological disability and brain atrophy in multiple sclerosis. BMC Neurol. 2019;19(1):23. https://doi.org/10.1186/s12883-019-1245-2.

Article  PubMed  PubMed Central  Google Scholar 

Hon GM, Hassan MS, van Rensburg SJ, Erasmus RT, Matsha T. The haematological profile of patients with multiple sclerosis. Open J Mod Neurosurg. 2012;2(3):36–44. https://doi.org/10.4236/ojmn.2012.23008.

Article  Google Scholar 

Naegele M, Tillack K, Reinhardt S, Schippling S, Martin R, Sospedra M. Neutrophils in multiple sclerosis are characterized by a primed phenotype. J Neuroimmunol. 2012;242(1–2):60–71. https://doi.org/10.1016/j.jneuroim.2011.11.009.

Article  CAS  PubMed  Google Scholar 

Haschka D, Tymoszuk P, Bsteh G, Petzer V, Berek K, Theurl I, et al. Expansion of neutrophils and classical and nonclassical monocytes as a hallmark in relapsing-remitting multiple sclerosis. Front Immunol. 2020;11:594. https://doi.org/10.3389/fimmu.2020.00594.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marcos-Ramiro B, García-Weber D, Millán J. TNF-induced endothelial barrier disruption: beyond actin and Rho. Thromb Haemost. 2014;112(6):1088–102. https://doi.org/10.1160/TH14-04-0299.

Article  CAS  PubMed  Google Scholar 

Akaishi T, Takahashi T, Nakashima I. Peripheral blood monocyte count at onset may affect the prognosis in multiple sclerosis. J Neuroimmunol. 2018;319:37–40. https://doi.org/10.1016/j.jneuroim.2018.03.016.

Article  CAS  PubMed  Google Scholar 

Woodberry T, Bouffler SE, Wilson AS, Buckland RL, Brüstle A. The emerging role of neutrophil granulocytes in multiple sclerosis. J Clin Med. 2018;7(12):511. https://doi.org/10.3390/jcm7120511.PMID:30513926;PMCID:PMC6306801.

Article  PubMed  PubMed Central  Google Scholar 

Aubé B, Lévesque SA, Paré A, Chamma É, Kébir H, Gorina R, et al. Neutrophils mediate blood-spinal cord barrier disruption in demyelinating neuroinflammatory diseases. J Immunol. 2014;193(5):2438–54. https://doi.org/10.4049/jimmunol.1400401.

Article  CAS  PubMed  Google Scholar 

Liu Y, Du X, Chen J, Jin Y, Peng L, Wang HHX, et al. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect. 2020;81(1):e6–12. https://doi.org/10.1016/j.jinf.2020.04.002.